Key facts
- Eupry’s last known valuation is $82.2M (Dec 2024).
- It has raised $40.2M; the latest was Later Stage VC ($24.1M) in Dec 2024.
- Notable investors include Denmark's Export and Investment Fund, Chr. Augustinus Fabriker, Sagitta Investments, Aage & Yelva Nimbs Foundation, Accelerace — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Eupry
- ·The full record, as it builds
Funding rounds
No funding rounds for Eupry are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eupry
Manufacturer of temperature and humidity compliance devices intended to support monitoring, calibration, and mapping for regulated industries. The company's product offers real-time monitoring, automated calibration, and mapping, enabling pharma, biotech, and healthcare logistics sectors to maintain compliance and simplify audits.
- Sector
- Information Technology
- HQ
- Copenhagen, Denmark
- Founded
- 2014
- Employees
- 105
- Website
- eupry.com/
- Ownership
- Privately Held (backing)
Eupry doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eupry shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eupry in its N-PORT filings yet. We sweep new filings monthly.